AKT inhibitor VIII(AKTi-1/2)
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
产品介绍
| CAS： | 612847-09-3 |
| 分子式： | C34H29N7O |
| 分子量： | 551.64 |
| 纯度： | >98% |
| 溶解性： | DMSO : 20 mg/mL (36.26 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble) |
| 存储： | Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month |
| 研究领域： | Cancer |
| Target： | Akt1：58 nM (IC50) |
| 描述： | AKT inhibitor VIII (AKTi-1/2) is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity with IC50s of |
m.cnreagent.com
